Norton Children's Hospital, formerly Kosair Children's Hospital, is a pediatric acute care children's hospital located in Louisville, Kentucky and affiliated with the University of Louisville School of Medicine.

There are 300 beds in Norton Children's Hospital.

During the past decade, Norton Children's Hospital conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 111 clinical trials were completed, i.e. on average, 122% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 39 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norton Children's Hospital" #1 sponsor was "Children's Oncology Group" with 145 trials, followed by "National Cancer Institute (NCI)" with 52 trials sponsored, "University of Louisville" with 10 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 5 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 146 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 11 trials as a collaborator, "Children's Oncology Group" with 8 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator and "National Institutes of Health (NIH)" with 3 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "Norton Children's Hospital" are "Recurrent Neuroblastoma" (18 trials), "Sarcoma" (16 trials), "Neuroblastoma" (15 trials), "Leukemia" (14 trials) and "Refractory Neuroblastoma" (13 trials). Many other conditions were trialed in "Norton Children's Hospital" in a lesser frequency.

Most popular intervention types in "Norton Children's Hospital" are "Drug" (205 trials), "Other" (114 trials), "Procedure" (87 trials), "Biological" (81 trials) and "Radiation" (63 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (60 trials), "Cyclophosphamide" (42 trials), "Vincristine Sulfate" (35 trials), "cyclophosphamide" (31 trials) and "Etoposide" (30 trials). Other intervention names were less common.

The vast majority of trials in "Norton Children's Hospital" are 269 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Norton Children's Hospital". undefined are not yet recruiting, 51 are recruiting, 56 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 145 completed trials in Norton Children's Hospital, 3 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Norton Children's Hospital, 13 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 113 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 17 trials that are defined as “Not Applicable".

Norton Children's Hospital has several departments that took part in Clinical trials: "Novak Center for Children's Health" - 6 trials, "Norton Children's Hospital - University of Louisville" - 2 trials, "Norton Children's Research Institute" - 2 trials